Brief: NovaBay Pharmaceuticals Announces Pricing Of $3.5 Mln Underwritten Public Offering
July 26 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS ANNOUNCES PRICING OF $3.5 MILLION
UNDERWRITTEN PUBLIC OFFERING
* NOVABAY PHARMACEUTICALS INC - 3.2 MILLION SHARES OF COMMON
STOCK
AND WARRANTS AT A COMBINED PUBLIC OFFERING PRICE OF $1.10
Source text for Eikon: ID:nBw1snVrMa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing